Susquehanna International Group’s NextCure NXTC Stock Holding History
Bought
Maintained
Sold
Other funds holding NXTC
SI
AAA
P
CCC
CPA
Susquehanna International Group's NXTC Position: Q3 2025 in Review
Susquehanna International Group sold out of NextCure (NXTC) in Q3 2025, closing a stake of 2,459 shares — an estimated $13.6K sold.
Susquehanna International Group first reported a position in NXTC in Q4 2019 and held it in 12 quarters. The position peaked at $542K in Q4 2021. 17 funds tracked by Wall St. Rank hold NXTC as of Q3 2025.
- Susquehanna International Group reported no remaining NextCure position as of Q3 2025 after selling out during the quarter.
- Susquehanna International Group sold 2,459 NextCure shares in Q3 2025, an estimated $13.6K.
- Susquehanna International Group first reported a position in NextCure in Q4 2019 and held it in 12 quarters.
- Susquehanna International Group's NextCure position peaked at $542K in Q4 2021.
- 17 funds tracked by Wall St. Rank held NextCure as of Q3 2025.
Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.